Saturday, Feb 24 2018 | Time 15:07 Hrs(IST)
image
image image
  • Rahul Gandhi arrives in Karnataka for second leg of Election campaign
  • We must guard against growing intolerance in society: Rahul on lynching of tribal in Kerala
  • Govt running away from responsibility in PNB bank scam: Cong
  • New US Embassy in Jerusalem in May
  • 9 killed and 20 others injured after a speeding vehicle hit them
  • Film on Cauvery ordeal released by Cycle Pure Agarbathies
  • KKR to announce their next captain LIVE on the Star Sports network
  • KKR to announce their next captain LIVE on the Star Sports network
  • Ledecka doubles up with historical PGS gold
  • Pak troops again violate ceasefire in Uri sector
  • Bank fraud cases will impact ease of doing business in India: Jaitley
  • Idea Cellular raises Rs 3,500 crore through QIP placement
  • Ashish, Rakesh, Aruna qualify for finals in respective categories of 2018 Gymnastic WC
  • Ashish, Rakesh, Aruna qualify for finals in respective categories of 2018 Gymnastic WC
  • PM Modi to visit Puducherry tomorrow
Business Economy Share

Cipla launches of Hepcvir-L for Chronic Hepatitis C Genotype 1 Patients

Mumbai, Dec 21 (UNI) Pharma major, Cipla Ltd, today announced the
launch of generic drug Ledipasvir-Sofosbuvir in India under the
brand name Hepcvir-L. Hepcvir-L is the first once-a-day, fixed-dose
oral combination therapy that has been approved for chronic
hepatitis C genotype 1 patients.
The introduction of the Ledipasvir-Sofosbuvir fixed-dose oral
combination thereby provides a new interferon and ribavirin-free
treatment option to patients and is a powerful weapon to fight
against genotype 1 hepatitis C virus.
Commenting on the launch of Ledipasvir-Sofosbuvir, Mr. Subhanu
Saxena, MD & Global CEO, Cipla Limited said, ''Cipla has always
tried to provide best-in-class affordable medicines to patients and
the launch of Ledipasvir-Sofosbuvir is a further step to facilitate
the optimal treatment for patients suffering from genotype 1
hepatitis C virus.''
UNI JS NV AW1235
More News
Sensex rises by 131.39 points on firm global cues.

Sensex rises by 131.39 points on firm global cues.

24 Feb 2018 | 1:25 PM

Mumbai, Feb 24 (UNI) The Bemch Mark Index of the Bombay Stock Exchange (BSE) rose 131 point 39 points or 0.38 percent to settle at 34,142.15 in the week under review as recovery materialized towards the end of the week supported by firm global stocks.

 Sharesee more..

Kottayam-Kochi Rubber Market Rates

24 Feb 2018 | 1:06 PM

Kottayam, Feb 24 (UNI) Following were the Rubber Market rates
announced by the Rubber Board here today per quintal

KOTTAYAM

RSS FOUR Rs 12400
RSS FIVE Rs 12100

KOCHI

RSS FOUR Rs.

 Sharesee more..
Sadbhav Engineering Ltd declared L1 by NHAI for road project in UP

Sadbhav Engineering Ltd declared L1 by NHAI for road project in UP

24 Feb 2018 | 1:01 PM

Mumbai, Feb 24 (UNI) Sadbhav Engineering Ltd said that company has
been declared the successful bidder (L1) by National Highway
Authority of India (NHAI) for the project/works on EPC Mode.

 Sharesee more..

Wholesale prices of Oils, Sugar, Commodities in APMC Market

24 Feb 2018 | 1:00 PM

Bengaluru, Feb 24(UNI) Following were the wholesale prices in the Bengaluru market on Saturday.

 Sharesee more..

Sugar rates steady in Kolhapur market today

24 Feb 2018 | 12:46 PM

Kolhapur, Feb 24 (UNI) The prices of M 30 and S 30 grades of sugar
remained steady in Kolhapur sugar market today at Rs 3180/3200 and
Rs 3080/3100 per quintal respectively.

 Sharesee more..
image